CURE Childhood Cancer Proudly Announces $5 Million in Research Grants

SAVANNAH, Ga. - Aug. 28, 2023 - PRLog -- CURE Childhood Cancer, the only organization providing financial and emotional support to local children and families while raising funds to further critical research specifically for childhood cancer treatments, announces $5 million in research grants for its 2022-2023 fiscal year. The grants have been awarded to top scientists at leading pediatric cancer research institutions across the nation and represent CURE's highest disbursement in a single grant cycle. This brings CURE's total investment in research over the last 17 years to more than $44 million. New for this grant cycle, CURE is awarding two-year grants in both its Early Investigators and Translation to CURE Award groupings.

"We are so pleased and proud that CURE is providing an outstanding level of support to very promising research this year," said Kristin Connor, CEO of CURE Childhood Cancer. "We opted to fund two-year grants this year so researchers can focus on finding cures rather than finding funding. All of the grants aim to make better-tolerated and less-toxic therapies, with a special emphasis on relapsed and refractory disease where current treatments are quite noxious and often not very effective for children."

CURE's funding decisions are guided by its Peer Review Committee, a group of practicing oncologists and academic scientists who conduct a rigorous review of more than 50 proposals to assess both scientific merit and alignment with CURE's goals. Of those proposals, CURE selected 11 studies to fund, most of which offer hope of testing more effective treatments for childhood cancers with poor prognosis within 2-3 years.

"Using their collective expertise in research and the clinical care of children with cancer, the committee selected the most innovative investigators and beneficial research projects through a national competition submitted in March 2023," said William C. Phelps, PhD, leader of CURE's Peer Review Committee. "Independent, comprehensive, and confidential peer review ensures that CURE's investments in research are focused on those projects most likely to significantly improve outcomes for children with cancer."

CURE's 2023 Pediatric Cancer Research Initiative includes the following studies:

Children's Healthcare of Atlanta/Emory University

• Aflac Precision Medicine Program – $1.5 million. Advances in precision medicine have helped scientists design studies targeting specific molecular pathways required for cancer growth. Shared information from multi-institutional programs is giving investigators the needed insights to research new treatments and clinical trials to reach children sooner than before.

To view the full list of awarded grants, visit https://ceciliarussomarketing.com/cure-childhood-cancer-p...